Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.14−0.10 (-4.46%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Biodexa Pharmaceuticals gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2017 it was 674.6%, against 472.9% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 674.6% | +201.8 |
| FY2016 | Dec 31, 2016 | 472.9% | +378.0 |
| FY2015 | Dec 31, 2015 | 94.9% | – |
See a number that looks wrong?